Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-17

Clinical Trial Update: Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of Xuesaitong Soft Capsule in patients with coronary artery disease and unstable angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xuesaitong Soft Capsule

Snippet

Sponsor: Jie Wang | Conditions: Coronary Heart Disease, Unstable Angina | Phase 2 | Status: UNKNOWN